Literature DB >> 24476956

Periostin is upregulated in coronary arteriopathy in Kawasaki disease and is a potential diagnostic biomarker.

Rebecca Reindel1, Kwang-Youn A Kim, Susan C Baker, Stanford T Shulman, Elizabeth J Perlman, Mark W Lingen, Cynthia Trevenen, Anne H Rowley.   

Abstract

Periostin was upregulated 11-fold in acute and chronic Kawasaki disease coronary arteries compared with controls (P = 0.003). Kawasaki disease patients had significantly elevated serum periostin values compared with febrile controls (P = 0.0086). There was no relationship between serum periostin values and age, gender or acute phase reactants; there was a relationship between serum periostin and maximal coronary artery Z scores that did not reach significance (P = 0.08). Periostin may prove to be useful as a component of a future diagnostic biomarker panel for Kawasaki Disease.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24476956      PMCID： PMC4086943          DOI： 10.1097/INF.0000000000000233

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  15 in total

Review 1.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

2.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

3.  Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide.

Authors:  Kazunari Kaneko; Ken Yoshimura; Atsushi Ohashi; Takahisa Kimata; Tomohiko Shimo; Shoji Tsuji
Journal:  Pediatr Cardiol       Date:  2011-04-13       Impact factor: 1.655

4.  Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions.

Authors:  T Matsubara; S Furukawa; K Yabuta
Journal:  Clin Immunol Immunopathol       Date:  1990-07

5.  Cardiovascular biomarkers in acute Kawasaki disease.

Authors:  Yuichiro Z Sato; Delaram P Molkara; Lori B Daniels; Adriana H Tremoulet; Chisato Shimizu; John T Kanegaye; Brookie M Best; James V Snider; Jeffrey R Frazer; Alan Maisel; Jane C Burns
Journal:  Int J Cardiol       Date:  2011-07-20       Impact factor: 4.164

6.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

7.  Serum-soluble receptors for tumor necrosis factor-alpha and interleukin-2, and neopterin in acute rheumatic fever.

Authors:  M Y Samsonov; G P Tilz; V P Pisklakov; G Reibnegger; E L Nassonov; V A Nassonova; H Wachter; D Fuchs
Journal:  Clin Immunol Immunopathol       Date:  1995-01

8.  Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.

Authors:  Nagib Dahdah; Ana Siles; Anne Fournier; Jocelyne Cousineau; Edgard Delvin; Claire Saint-Cyr; Linda Spiegelblatt; Yvette Bonny; Michèle Vartian; Martine Montigny
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

9.  A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses.

Authors:  Xuefeng B Ling; Kenneth Lau; John T Kanegaye; Zheng Pan; Sihua Peng; Jun Ji; Gigi Liu; Yuichiro Sato; Tom T S Yu; John C Whitin; James Schilling; Jane C Burns; Harvey J Cohen
Journal:  BMC Med       Date:  2011-12-06       Impact factor: 8.775

10.  Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study.

Authors:  Jan Marc Orenstein; Stanford T Shulman; Linda M Fox; Susan C Baker; Masato Takahashi; Tricia R Bhatti; Pierre A Russo; Gary W Mierau; Jean Pierre de Chadarévian; Elizabeth J Perlman; Cynthia Trevenen; Alexandre T Rotta; Mitra B Kalelkar; Anne H Rowley
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240
View more
  4 in total

Review 1.  Kawasaki disease: insights into pathogenesis and approaches to treatment.

Authors:  Stanford T Shulman; Anne H Rowley
Journal:  Nat Rev Rheumatol       Date:  2015-04-28       Impact factor: 20.543

2.  Circulating Levels of IL-13, TGF-β1, and Periostin as Potential Biomarker for Coronary Artery Disease with Acute Heart Failure.

Authors:  Xuan Qiu; Fengyi Ma; Huanxin Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-08       Impact factor: 2.629

Review 3.  Kawasaki Disease and Coronary Artery Involvement: A Narrative Review.

Authors:  Kruthiga Rajasekaran; Shrimahitha Duraiyarasan; Mayowa Adefuye; Nisha Manjunatha; Vinutna Ganduri
Journal:  Cureus       Date:  2022-08-24

4.  The transcriptional profile of coronary arteritis in Kawasaki disease.

Authors:  Anne H Rowley; Kristine M Wylie; Kwang-Youn A Kim; Adam J Pink; Amy Yang; Rebecca Reindel; Susan C Baker; Stanford T Shulman; Jan M Orenstein; Mark W Lingen; George M Weinstock; Todd N Wylie
Journal:  BMC Genomics       Date:  2015-12-18       Impact factor: 3.969
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.